Compare Stocks → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:NICXFOTCMKTS:PRVCFOTCMKTS:RNUGFOTCMKTS:TGODF Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNICXFNicox$0.44$0.44$0.44▼$0.44$22.04M0.36N/AN/APRVCFPreveCeutical Medical$0.02$0.02$0.01▼$0.03$8.69M0.7362,669 shsN/ARNUGFReNeuron Group$0.00$0.04$0.00▼$0.05$63K0.52126 shsN/ATGODFGreen Organic Dutchman$0.01$0.04$0.16▼$1.25$595K2.2760,349 shs2.89 million shs7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNICXFNicox0.00%0.00%0.00%0.00%-30.84%PRVCFPreveCeutical Medical-12.90%+10.96%-8.47%-16.06%-23.94%RNUGFReNeuron Group0.00%0.00%-97.41%-97.86%-98.78%TGODFGreen Organic Dutchman-1.25%-32.13%-57.16%-77.61%-91.77%The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside himMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNICXFNicoxN/AN/AN/AN/AN/AN/AN/AN/APRVCFPreveCeutical MedicalN/AN/AN/AN/AN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/AN/AN/AN/AN/ATGODFGreen Organic DutchmanN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNICXFNicoxN/AN/AN/AN/APRVCFPreveCeutical MedicalN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/ATGODFGreen Organic DutchmanN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNICXFNicox$5.52M3.99N/AN/A$1.10 per share0.40PRVCFPreveCeutical MedicalN/AN/AN/AN/A($0.01) per shareN/ARNUGFReNeuron Group$640K0.10N/AN/A$0.11 per share0.01TGODFGreen Organic Dutchman$24.13M0.02N/AN/A$2.03 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNICXFNicox-$29.25MN/A0.00N/AN/AN/AN/AN/AN/APRVCFPreveCeutical Medical-$1.14MN/A0.00∞N/AN/AN/A-272.69%N/ARNUGFReNeuron Group-$6.52MN/A0.00∞N/AN/AN/AN/AN/ATGODFGreen Organic Dutchman-$33.62M-$0.41N/A∞N/A-83.86%-22.02%-14.58%N/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNICXFNicoxN/AN/AN/AN/AN/APRVCFPreveCeutical MedicalN/AN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/AN/ATGODFGreen Organic DutchmanN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNICXFNicoxN/AN/AN/APRVCFPreveCeutical MedicalN/A0.020.02RNUGFReNeuron Group0.081.51N/ATGODFGreen Organic Dutchman0.070.890.29OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNICXFNicoxN/APRVCFPreveCeutical MedicalN/ARNUGFReNeuron GroupN/ATGODFGreen Organic Dutchman0.44%Insider OwnershipCompanyInsider OwnershipNICXFNicoxN/APRVCFPreveCeutical MedicalN/ARNUGFReNeuron GroupN/ATGODFGreen Organic Dutchman8.70%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableNICXFNicox2850.10 millionN/ANot OptionablePRVCFPreveCeutical MedicalN/A535.30 millionN/ANot OptionableRNUGFReNeuron Group2657.17 millionN/ANot OptionableTGODFGreen Organic Dutchman4175.32 million68.77 millionNot OptionableTGODF, PRVCF, RNUGF, and NICXF HeadlinesSourceHeadlineAvocado mattress sales and deals for February: up to 20% off an organic bedtechradar.com - February 21 at 8:36 PMThe Best Organic Mattresses Are Eco-Friendly And A Dream To Sleep Onforbes.com - November 10 at 3:13 PMFine Organic trades in green after incorporating specialty chemicals armmoneycontrol.com - October 23 at 12:35 PMBowling Green State Universityusnews.com - July 25 at 9:28 PMGet Buried in a $1,000 Organic, Biodegradable Mushroom Coffinfuturism.com - June 20 at 2:58 PMGreen Organic Dutchman (OTC: TGOD.F)fool.com - May 27 at 11:04 PMGreen Bay, WIforbes.com - May 3 at 11:54 PMgreen hackshackaday.com - April 30 at 5:38 PMUnion College may drop Dutchmen/Dutchwomen nickname; Part of ongoing rebranding effort, college saysdailygazette.com - April 7 at 12:32 PMThe Green Organic Dutchman Holdings Ltd.: The Green Organic Dutchman Announces Name Change and New Chairmanfinanznachrichten.de - January 27 at 12:33 AMThe Green Organic Dutchman Announces Name Change and New Chairmanfinance.yahoo.com - January 25 at 8:47 AMThe Green Organic Dutchman Announces Release of Escrowed Shares and New Share Issuancefinance.yahoo.com - January 23 at 9:40 AMThe Green Organic Dutchman Holdings Ltd Ordinary Sharesmorningstar.com - January 23 at 12:28 AMThe Green Organic Dutchman Announces New Board Memberfinance.yahoo.com - January 11 at 9:38 AMIIROC Trading Halt - TGOD.WSfinance.yahoo.com - December 19 at 5:30 PMThe Green Organic Dutchman Holdings Ltd. Announces $6 Million Marketed Public Offering of Unitsfinance.yahoo.com - December 15 at 5:18 PMThe Green Organic Dutchman Announces Shares for Debt Transactionfinance.yahoo.com - November 30 at 10:42 AMThe Green Organic Dutchman Q3 Revenue Grows 36% YoY, Here Are The Detailsmsn.com - November 28 at 6:02 PMThe Green Organic Dutchman Holdings Ltd.: The Green Organic Dutchman Reports Third Quarter 2022 Resultsfinanznachrichten.de - November 24 at 7:59 AMThe Green Organic Dutchman Reports Third Quarter 2022 Resultsfinance.yahoo.com - November 23 at 9:54 PMThe Green Organic Dutchman to Release Q3 Financial Results on November 23rd 2022finance.yahoo.com - November 18 at 2:34 PMThe Green Organic Dutchman Completes Merger With BZAM Cannabismsn.com - November 4 at 11:26 AMGreen Organic Dutchman (OTCQX: TGODF) (CSE: TGOD) Set to Merge with BZAM Cannabis to Create the Sixth Largest Canadian LPmarkets.buffalonews.com - October 19 at 8:31 PMThe Green Organic Dutchman Signs A Definitive Agreement To Merge With BZAM Cannabismsn.com - October 19 at 3:31 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsNicoxOTCMKTS:NICXFNicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial. The company is also developing NCX 4251, a novel patented ophthalmic suspension of fluticasone propionate nanocrystals that is in Phase 2b clinical trial for the treatment of dry eye disease; and NCX 1728, an NO-donating Phosphodiesterase-5 inhibitor, which is in preclinical evaluation. It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was incorporated in 1996 and is headquartered in Valbonne, France.PreveCeutical MedicalOTCMKTS:PRVCFPreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.ReNeuron GroupOTCMKTS:RNUGFReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.Green Organic DutchmanOTCMKTS:TGODFThe Green Organic Dutchman Holdings Ltd. engages in the production, cultivation, processing, and distribution of cannabis and related products. Its products include cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis. The company was founded by Scott Skinner and Jeannette VanderMarel in 2012 and is headquartered in Mississauga, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.